Managing TBSRTC III thyroid nodules: evaluating repeat FNA, molecular testing, and surgery
Repeat FNA resolved approximately 50% of cases, with no significant differences in malignancy or surgical intervention rates compared to molecular testing. Repeat FNA is the most cost-effective initial step for managing AUS nodules. Prebiopsy ultrasonography had limited utility in stratifying malignancy risk for AUS nodules.
Authors
- Daniel L. Miller (ORCID: https://orcid.org/0000-0002-2104-4614)
- Christopher Dilli
- William Mi
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Washington University in St. Louis (US)
- Saint Louis University (US)
Publication Details
- Journal
- Journal of the American Society of Cytopathology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1016/j.jasc.2025.05.007
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00